Valneva (VALN) News Today $5.75 +0.10 (+1.77%) (As of 11/1/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Valneva’s Chikungunya Vaccine Gains Scientific SpotlightOctober 22, 2024 | markets.businessinsider.comValneva to Present on Chikungunya at Several Leading Scientific ConferencesOctober 21, 2024 | globenewswire.comValneva and LimmaTech Awarded FDA Fast Track Designation for Tetravalent Shigella Vaccine Candidate S4VOctober 16, 2024 | globenewswire.comVaccine producer supports local cancer charity Team Jak FoundationOctober 15, 2024 | msn.comBrokers Set Expectations for Valneva SE's FY2024 Earnings (NASDAQ:VALN)Valneva SE (NASDAQ:VALN - Free Report) - Investment analysts at HC Wainwright decreased their FY2024 earnings estimates for Valneva in a research note issued to investors on Friday, October 11th. HC Wainwright analyst E. White now forecasts that the company will earn $0.00 per share for the year,October 14, 2024 | marketbeat.comBuy Rating for VALN: Strong Vaccine Pipeline and Financial UpsideOctober 11, 2024 | markets.businessinsider.comHigh Growth Tech Stocks In France October 2024October 11, 2024 | uk.finance.yahoo.comValneva (NASDAQ:VALN) Price Target Cut to $20.00HC Wainwright cut their price objective on Valneva from $23.00 to $20.00 and set a "buy" rating on the stock in a research report on Friday.October 11, 2024 | marketbeat.comValneva Scotland supports local cancer charity Team Jak FoundationOctober 10, 2024 | msn.comValneva Hosts Investor Day in New York CityOctober 10, 2024 | globenewswire.comValneva SE (INRLF) (H1 2024) Earnings Call Highlights: Navigating Growth Amidst Revenue ChallengesOctober 9, 2024 | finance.yahoo.comExclusive Networks And 2 High Growth Tech Stocks In FranceOctober 9, 2024 | uk.finance.yahoo.comValneva (NASDAQ:VALN) Stock Quotes, Forecast and News SummaryOctober 3, 2024 | benzinga.comValneva to Host Investor Day in New York on Thursday, October 10, 2024 at 10:00 AM ETOctober 3, 2024 | globenewswire.comHigh Growth Tech Stocks In France Featuring Bolloré And Two MoreSeptember 30, 2024 | finance.yahoo.comValneva’s Growth Prospects and Market Undervaluation Justify a Buy RatingSeptember 27, 2024 | markets.businessinsider.comValneva SE to Post Q3 2024 Earnings of ($0.29) Per Share, HC Wainwright Forecasts (NASDAQ:VALN)Valneva SE (NASDAQ:VALN - Free Report) - Analysts at HC Wainwright increased their Q3 2024 EPS estimates for Valneva in a research report issued to clients and investors on Wednesday, September 25th. HC Wainwright analyst E. White now forecasts that the company will post earnings per share of ($0September 27, 2024 | marketbeat.comBuy Rating Affirmed for Valneva Amidst Promising Vaccine Development and Financial ProspectsSeptember 25, 2024 | markets.businessinsider.comIn-Depth Examination Of 6 Analyst Recommendations For ValnevaSeptember 25, 2024 | benzinga.comHC Wainwright Cuts Valneva (NASDAQ:VALN) Price Target to $23.00HC Wainwright lowered their price objective on Valneva from $26.00 to $23.00 and set a "buy" rating on the stock in a research report on Wednesday.September 25, 2024 | marketbeat.comFrance stocks mixed at close of trade; CAC 40 up 0.10%September 24, 2024 | msn.comValneva SE (AYJ.F) Stock Price, News, Quote & History - Yahoo FinanceSeptember 23, 2024 | finance.yahoo.comValneva Scotland glows orange for World Patient Safety DaySeptember 18, 2024 | msn.comValneva Seeks Approval To Expand IXCHIQ Chikungunya Vaccine Use To Adolescents In Europe And CanadaSeptember 18, 2024 | markets.businessinsider.comValneva eyes teenage label for chikungunya vaccine in Europe and CanadaSeptember 18, 2024 | finance.yahoo.comValneva Submits Label Extension Applications for its Chikungunya Vaccine, IXCHIQ®, to EMA and Health CanadaSeptember 18, 2024 | globenewswire.comKepler Capital Sticks to Their Buy Rating for Valneva (0OB3)September 15, 2024 | markets.businessinsider.comValneva Announces the Success of its Private Placement Raising approximately €60 MillionSeptember 13, 2024 | globenewswire.comValneva Announces the Launch of a Private Placement of Ordinary Shares for Approximately 60 Million EurosSeptember 12, 2024 | globenewswire.comLivingston MP tours site of Scotland’s largest vaccine producerSeptember 6, 2024 | msn.comBuy Rating for Valneva Amid Promising VLA15 Vaccine Prospects and Strong Revenue ForecastsSeptember 3, 2024 | markets.businessinsider.comThe Analyst Landscape: 6 Takes On ValnevaSeptember 3, 2024 | benzinga.comPfizer And Valneva Partnered Lyme Disease Vaccine Shows Effectiveness As Booster Shot In Mid-Stage StudySeptember 3, 2024 | msn.comPfizer and Valneva report positive results in mid-stage trial of Lyme disease vaccineSeptember 3, 2024 | msn.comValneva (NASDAQ:VALN) Sees Unusually-High Trading VolumeValneva (NASDAQ:VALN) Sees Unusually-High Trading VolumeSeptember 3, 2024 | marketbeat.comValneva's (VALN) "Buy" Rating Reiterated at HC WainwrightHC Wainwright restated a "buy" rating and issued a $26.00 price objective on shares of Valneva in a research report on Tuesday.September 3, 2024 | marketbeat.comPfizer, Valneva Report Positive Lyme Disease Vaccine Candidate DataSeptember 3, 2024 | marketwatch.comEuropean Shares Edge Lower Before US PMI DataSeptember 3, 2024 | markets.businessinsider.comValneva and Pfizer report positive data from trial of Lyme disease vaccine boosterSeptember 3, 2024 | finance.yahoo.comPfizer, Valneva Report Further Positive Phase 2 Booster Results For Lyme Disease Vaccine CandidateSeptember 3, 2024 | markets.businessinsider.comValneva and Pfizer Report Further Positive Phase 2 Booster Results for Lyme Disease Vaccine CandidateSeptember 3, 2024 | globenewswire.comValneva (NASDAQ:VALN) Shares Down 3.3% Valneva (NASDAQ:VALN) Shares Down 3.3%August 29, 2024 | marketbeat.comThe most dangerous mosquito-borne diseasesAugust 23, 2024 | msn.comValneva (NASDAQ:VALN) Shares Gap Down to $8.42Valneva (NASDAQ:VALN) Shares Gap Down to $8.42August 21, 2024 | marketbeat.comValneva (NASDAQ:VALN) Sees Large Volume IncreaseValneva (NASDAQ:VALN) Sees Unusually-High Trading VolumeAugust 20, 2024 | marketbeat.comgetting malaria as a child shaped my life and gave purpose to my career - Greig RooneyAugust 20, 2024 | msn.comValneva SE (AYJ.F)August 17, 2024 | finance.yahoo.comValneva SE (AYJ0.MU)August 16, 2024 | sg.finance.yahoo.comValneva SE (INRLF)August 15, 2024 | finance.yahoo.comBuy Rating on Valneva Amid Strong Q2 Performance and Promising Lyme Vaccine OutlookAugust 14, 2024 | markets.businessinsider.com Get Valneva News Delivered to You Automatically Sign up to receive the latest news and ratings for VALN and its competitors with MarketBeat's FREE daily newsletter. Email Address 625,000% Gain (Ad)Imagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz. >> Dive into the Workshop Here VALN Media Mentions By Week VALN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. VALN News Sentiment▼0.000.43▲Average Medical News Sentiment VALN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. VALN Articles This Week▼04▲VALN Articles Average Week Get Valneva News Delivered to You Automatically Sign up to receive the latest news and ratings for VALN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies IMCR News SNDX News TECX News SPRY News RCKT News RXRX News CNTA News RCUS News TYRA News TARS News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:VALN) was last updated on 11/2/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredMusk Says ‘Dollar Will Be Worth Nothing…’Elon Musk just issued an urgent warning… It's no secret that Musk is able to move markets with his words…Crypto 101 Media | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | SponsoredNvidia warning urgentI thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredNothing can stop this gold rallyAfter what's felt like nearly a decade of disappointing gains, gold is stronger than ever and continues to hit...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Valneva SE Please log in to your account or sign up in order to add this asset to your watchlist. Share Valneva With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
